A randomised double-blind, double dummy trial to compare the efficacy and safety of Arimidex [anastrozole] with tamoxifen as first line therapy for advanced breast cancer in post-menopausal women

Trial Profile

A randomised double-blind, double dummy trial to compare the efficacy and safety of Arimidex [anastrozole] with tamoxifen as first line therapy for advanced breast cancer in post-menopausal women

Completed
Phase of Trial: Phase III

Latest Information Update: 12 Dec 2005

At a glance

  • Drugs Anastrozole; Tamoxifen
  • Indications Advanced breast cancer; Breast cancer; Menopause
  • Focus Registrational; Therapeutic Use
  • Acronyms TARGET
  • Sponsors AstraZeneca
  • Most Recent Events

    • 12 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top